EyePoint Pharmaceuticals, Inc. Insider Transactions
EyePoint Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
GUYER DAVID R
Director |
Sell | 11,625 @ $10.30 | $119,705 | 3,700 | 06/03/2024 | 06/04/2024 | |
|
GUYER DAVID R
Director |
Sell | 11,625 @ $12.65 | $147,045 | 5,550 | 05/14/2024 | 05/16/2024 | |
|
Cormorant Asset Management, LP
10 percent owner |
Buy | 207,153 @ $12.36 | $2.56 M | 8,325,000 | 05/06/2024 | 05/08/2024 | |
|
Cormorant Asset Management, LP
10 percent owner |
Buy | 642,847 @ $11.70 | $7.52 M | 8,117,847 | 05/06/2024 | 05/08/2024 | |
|
Cormorant Asset Management, LP
10 percent owner |
Buy | 395,244 @ $17.62 | $6.96 M | 7,288,479 | 04/18/2024 | 04/22/2024 | |
|
Cormorant Asset Management, LP
10 percent owner |
Buy | 186,521 @ $18.90 | $3.53 M | 7,475,000 | 04/18/2024 | 04/22/2024 | |
|
Jones David Scott
SVP & Chief Commercial Officer |
Sell | 209 @ $28.49 | $5,954 | 37,962 | 02/02/2024 | 02/05/2024 | |
|
Paggiarino Dario A.
Chief Medical Officer |
Sell | 33,665 @ $25.77 | $867,672 | 36,505 | 01/26/2024 | 01/30/2024 | |
|
Jones David Scott
SVP & Chief Commercial Officer |
Sell | 9,604 @ $25.27 | $242,717 | 37,962 | 01/26/2024 | 01/29/2024 | |
|
Paggiarino Dario A.
Chief Medical Officer |
Sell | 51 @ $25.41 | $1,296 | 85,779 | 01/26/2024 | 01/30/2024 | |
|
Paggiarino Dario A.
Chief Medical Officer |
Sell | 15,609 @ $25.41 | $396,572 | 70,170 | 01/26/2024 | 01/30/2024 | |
|
Jones David Scott
SVP & Chief Commercial Officer |
Sell | 16,413 @ $25.45 | $417,653 | 47,566 | 01/26/2024 | 01/29/2024 | |
|
Paggiarino Dario A.
Chief Medical Officer |
Sell | 300 @ $25.00 | $7,500 | 36,505 | 01/25/2024 | 01/29/2024 | |
|
Jones David Scott
SVP & Chief Commercial Officer |
Sell | 300 @ $25.00 | $7,500 | 37,962 | 01/25/2024 | 01/26/2024 | |
|
Jones David Scott
SVP & Chief Commercial Officer |
Sell | 5,700 @ $25.01 | $142,554 | 43,562 | 01/24/2024 | 01/26/2024 |
EyePoint Pharmaceuticals, Inc. FAQ's
Who is on EyePoint Pharmaceuticals, Inc.'s Insider Roster?
The list of insiders at EyePoint Pharmaceuticals, Inc. includes Jones David Scott, Paggiarino Dario A., Cormorant Asset Management, LP, GUYER DAVID R.
How much insider selling is happening at EyePoint Pharmaceuticals, Inc.?
Insiders have sold a total of 105,101 EyePoint Pharmaceuticals, Inc. shares in the last 12 months for a total of 2.36 M sold.
Which EyePoint Pharmaceuticals, Inc. insiders have been selling company stock?
The following insiders have sold EyePoint Pharmaceuticals, Inc. shares in the last 12 months: Jones David Scott ($816,378), Paggiarino Dario A. ($1.27 M), GUYER DAVID R ($266,750),
How much insider buying is happening at EyePoint Pharmaceuticals, Inc.?
Insiders have purchased a total of 1.43 M EyePoint Pharmaceuticals, Inc. shares in the last 12 months for a total of 20.57 M.
Which EyePoint Pharmaceuticals, Inc. insiders have been buying company stock?
The following insiders have purchased EyePoint Pharmaceuticals, Inc. shares in the last 12 months: Cormorant Asset Management, LP ($20.57 M),